Mental changes with Revlimid (Lenalidomide) are not explicitly mentioned as a reason to avoid CAR T-cell therapy in the provided context. However, it's important to note that both treatments can have significant side effects, including those affecting the nervous system. For example, CAR T-cell therapy can lead to cytokine Show Full Answer

Mental changes with Revlimid (Lenalidomide) are not explicitly mentioned as a reason to avoid CAR T-cell therapy in the provided context. However, it's important to note that both treatments can have significant side effects, including those affecting the nervous system. For example, CAR T-cell therapy can lead to cytokine release syndrome and nervous system problems. Always consult with your oncologist to determine the best treatment plan for your specific situation.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Revlimid (Lenalidomide) for Myeloma | MyMyelomaTeam

Myeloma Treatments: Risks and Benefits | MyMyelomaTeam